
pmid: 28274362
Patients with rosacea present a challenge to the dermatologist, as they typically possess sensitive skin, need facial Demodex and bacterial colonization control, exhibit vasomotor instability, require camouflaging of telangiectatic mats, and desire prescription treatment. Currently available pharmaceuticals are aimed at inflammation reduction, primarily with the use of topical and oral antibiotics. Recently, vasoconstrictor formulations have emerged, but these drugs have only a temporary effect and improve appearance without addressing the underlying cause, which remains largely unknown. Cosmeceuticals, including cleansers, moisturizers, cosmetics, sunscreens, and anti-inflammatory botanicals, can be used as adjuvant therapies in combination with traditional therapies. This review explores the effective use of cosmeceuticals in the treatment of rosacea to enhance pharmaceutical outcomes and meet patient expectations in a more satisfactory manner.
Cosmeceuticals, Rosacea, Humans, Cosmetics, Sunscreening Agents, Anti-Bacterial Agents
Cosmeceuticals, Rosacea, Humans, Cosmetics, Sunscreening Agents, Anti-Bacterial Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 20 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
